Related Experiment Video
Updated: Feb 22, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Recent Advances in Understanding and Managing Cardiomyopathy
Paulino Alvarez1, Wh Wilson Tang1,2
1Department of Cardiovascular Medicine, Heart and Vascular Institute , Cleveland Clinic, Cleveland, Ohio, USA.
Cardiomyopathy, a leading cause for heart transplants, is being transformed by genetic testing and stem cell research. New therapies like gene therapy and small molecules are advancing precision medicine for heart muscle diseases.
Area of Science:
- Cardiology
- Genetics
- Regenerative Medicine
Background:
- Cardiomyopathy is a primary diagnosis for heart transplant recipients globally.
- It involves heart muscle dysfunction unrelated to other common cardiac conditions.
- Genetic factors play a significant role in its development.
Purpose of the Study:
- To highlight advancements in genetic testing for cardiomyopathy.
- To explore the potential of patient-specific stem cells in disease modeling.
- To review emerging therapeutic strategies for cardiomyopathy.
Main Methods:
- Next-generation sequencing for genetic analysis.
- Utilizing patient-derived pluripotent stem cells for in vitro studies.
- Evaluating novel treatments in clinical trials.
Main Results:
- Next-generation sequencing promises to revolutionize cardiomyopathy genetic diagnostics.
- Patient-specific stem cell-derived cardiomyocytes offer a platform for personalized disease modeling.
- Clinical trials are investigating stem cell therapy, gene therapy, RNA interference, and small molecules.
Conclusions:
- Genetic testing and stem cell technology are pivotal for advancing cardiomyopathy research.
- Precision medicine approaches are emerging as a new frontier for treating heart muscle diseases.
- Ongoing clinical trials indicate a promising future for novel cardiomyopathy therapeutics.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy